BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 33336432)

  • 1. Usefulness of CogEvo, a computerized cognitive assessment and training tool, for distinguishing patients with mild Alzheimer's disease and mild cognitive impairment from cognitively normal older people.
    Takechi H; Yoshino H
    Geriatr Gerontol Int; 2021 Feb; 21(2):192-196. PubMed ID: 33336432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Mild Cognitive Impairment Using CogEvo: A Computerized Cognitive Function Assessment Tool.
    Satoh T; Sawada Y; Saba H; Kitamoto H; Kato Y; Shiozuka Y; Kuwada T; Shima S; Murakami K; Sasaki M; Abe Y; Harano K
    J Prim Care Community Health; 2024; 15():21501319241239228. PubMed ID: 38504559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CogEvo, a cognitive function balancer, is a sensitive and easy psychiatric test battery for age-related cognitive decline.
    Ichii S; Nakamura T; Kawarabayashi T; Takatama M; Ohgami T; Ihara K; Shoji M
    Geriatr Gerontol Int; 2020 Mar; 20(3):248-255. PubMed ID: 31851431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity and reliability of a computerized cognitive function evaluation battery (CogEvo) as a screening tool.
    Sawada Y; Satoh T; Saba H; Kitamoto H; Kato Y; Shiozuka Y; Kuwada T; Murakami K; Sasaki M; Abe Y; Harano K
    PCN Rep; 2023 Mar; 2(1):e67. PubMed ID: 38868415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy and Psychometric Properties of the Brazilian Version of the Montreal Cognitive Assessment as a Brief Screening Tool for Mild Cognitive Impairment and Alzheimer's Disease in the Initial Stages in the Elderly.
    Pinto TCC; Machado L; Costa MLG; Santos MSP; Bulgacov TM; Rolim APP; Silva GA; Rodrigues-Júnior AL; Sougey EB; Ximenes RCC
    Dement Geriatr Cogn Disord; 2019; 47(4-6):366-374. PubMed ID: 31466064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation study of the Alzheimer's Disease Assessment Scale-Cognitive Subscale for people with mild cognitive impairment and Alzheimer's disease in Chinese communities.
    Yang H; Cheng Z; Li Z; Jiang Y; Zhao J; Wu Y; Gu S; Xu H
    Int J Geriatr Psychiatry; 2019 Nov; 34(11):1658-1666. PubMed ID: 31347192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive profiles and optimal cut-offs for routine cognitive tests in elderly individuals with Parkinson's disease, Parkinson's disease dementia, Alzheimer's disease, and normal cognition.
    Phannarus H; Muangpaisan W; Siritipakorn P; Chotinaiwattarakul W
    Psychogeriatrics; 2020 Jan; 20(1):20-27. PubMed ID: 30912230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment.
    Ba M; Ng KP; Gao X; Kong M; Guan L; Yu L;
    Eur J Neurol; 2019 May; 26(5):733-e53. PubMed ID: 30561868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Normative Adjustments to the Montreal Cognitive Assessment.
    Pugh EA; Kemp EC; van Dyck CH; Mecca AP; Sharp ES;
    Am J Geriatr Psychiatry; 2018 Dec; 26(12):1258-1267. PubMed ID: 30314940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spanish version of the Mattis Dementia Rating Scale-2 for early detection of Alzheimer's disease and mild cognitive impairment.
    Boycheva E; Contador I; Fernández-Calvo B; Ramos-Campos F; Puertas-Martín V; Villarejo-Galende A; Bermejo-Pareja F
    Int J Geriatr Psychiatry; 2018 Jun; 33(6):832-840. PubMed ID: 28332732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the Montreal Cognitive Assessment (MoCA) screening superior to the Mini-Mental State Examination (MMSE) in the detection of mild cognitive impairment (MCI) and Alzheimer's Disease (AD) in the elderly?
    Pinto TCC; Machado L; Bulgacov TM; Rodrigues-Júnior AL; Costa MLG; Ximenes RCC; Sougey EB
    Int Psychogeriatr; 2019 Apr; 31(4):491-504. PubMed ID: 30426911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Validation Study of the Inbrain CST: a Tablet Computer-based Cognitive Screening Test for Elderly People with Cognitive Impairment.
    Chin J; Kim DE; Lee H; Yun J; Lee BH; Park J; Yeom J; Shin DS; Na DL
    J Korean Med Sci; 2020 Aug; 35(34):e292. PubMed ID: 32864906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability and validity of A Quick Test of Cognitive Speed for detecting early-stage dementia in elderly Japanese.
    Takahashi F; Awata S; Sakuma N; Inagaki H; Ijuin M
    Psychogeriatrics; 2012 Jun; 12(2):75-82. PubMed ID: 22712639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond the Mini-Mental State Examination: The Use of Physical and Spatial Navigation Tests to Help to Screen for Mild Cognitive Impairment and Alzheimer's Disease.
    Plácido J; Ferreira JV; Araújo J; Silva FO; Ferreira RB; Guimarães C; de Carvalho AN; Laks J; Deslandes AC
    J Alzheimers Dis; 2021; 81(3):1243-1252. PubMed ID: 33935093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrimination ability of the Short Test of Mental Status (STMS) compared to the Mini Mental State Examination (MMSE) in the spectrum of normal cognition, mild cognitive impairment, and probable Alzheimer's disease dementia: The Turkish standardization study.
    Çebi M; Babacan G; Öktem Tanör Ö; Gürvit H
    J Clin Exp Neuropsychol; 2020 Jul; 42(5):450-458. PubMed ID: 32406297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Memory performance on the story recall test and prediction of cognitive dysfunction progression in mild cognitive impairment and Alzheimer's dementia.
    Park JH; Park H; Sohn SW; Kim S; Park KW
    Geriatr Gerontol Int; 2017 Oct; 17(10):1603-1609. PubMed ID: 27910252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychometric Properties of Alzheimer's Disease Assessment Scale-Cognitive Subscale for Mild Cognitive Impairment and Mild Alzheimer's Disease Patients in an Asian Context.
    Zainal NH; Silva E; Lim LL; Kandiah N
    Ann Acad Med Singap; 2016 Jul; 45(7):273-83. PubMed ID: 27523508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining cognitive screening tests for the evaluation of mild cognitive impairment in the elderly.
    Ladeira RB; Diniz BS; Nunes PV; Forlenza OV
    Clinics (Sao Paulo); 2009; 64(10):967-73. PubMed ID: 19841703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.